About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Histograft
Betuvax
Nextgen
Gemabank
Genetico
Biotechnology Developments
Genotarget
Reprobank
Vitacel
01.02.2024
Press releases
The Ministry of Health issued permission to Artgen Biotech to conduct clinical trials of an innovative drug for the treatment of cystitis
22.01.2024
Press releases
Artgen Biotech updated its development strategy
18.01.2024
Press releases
Results of Artgen Biotech activities for 9 months of 2023
15.01.2024
Press releases
Histograft will conduct clinical trials of gene-activated material for the treatment of the spine
22.12.2023
Press releases
RBT shares became available for trading on the Moscow Exchange over-the-counter market
18.12.2023
Press releases
Gemabank shareholders approved share split and dividends
29.11.2023
Press releases
The first Russian database of genetic variants is used to make a diagnosis by 45% of specialists
1
…
7
8
9
10
11
…
17
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
